Menu Search
Equities

Jacobio Pharmaceuticals Group Co Ltd

1167:HKG.HS

Jacobio Pharmaceuticals Group Co Ltd

Actions
  • Price (HKD)1.69
  • Today's Change-0.06 / -3.43%
  • Shares traded3.79m
  • 1 Year change-49.85%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in CNYView more

In 2023, cash reserves at Jacobio Pharmaceuticals Group Co Ltd fell by 155.22m. Cash Flow from Financing totalled 246.28m or 387.72% of revenues. In addition the company used 364.20m for operations while cash used for investing totalled 48.00m.
Cash flow per share-0.4721
Price/Cash flow per share--
Book value per share1.26
Tangible book value per share1.26
More ▼

Balance sheet in CNYView more

Jacobio Pharmaceuticals Group Co Ltd appears to have little financial risk as the company holds a substantial amount of cash on its books. In fact, 0.34% of the market capitalization can be attributed to its 469.16m and debt could be paid in full if management chose.
Current ratio6.00
Quick ratio--
Total debt/total equity0.2186
Total debt/total capital0.1794
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.